EUVIMEDEUVIMED entdecken
Crossref

THERAPEUTIC SAFETY AND RATIONALITY IN CLINICAL PHARMACY: THE ROLE OF PRECLINICAL STUDIES AND THE ZEBRAFISH MODEL IN SUPPORTING CLINICAL DECISION-MAKING

Fauziah Hasdin, Wahyuni Agus

JURNAL PHARMA BHAKTA · 30.05.2026 · 6 (1) · 47-57

DOI: 10.56710/jpb.v6i1.169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JURNAL PHARMA BHAKTA, online erschienen am 30.05.2026. Verfasst von Fauziah Hasdin und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical pharmacy practice requires the implementation of safe and rational therapies to optimize clinical outcomes and minimize the risk of adverse drug reactions. Limited availability of early clinical data, particularly for newly developed drugs and the increasing use of natural products, poses challenges in therapeutic decision-making. Under these conditions, preclinical studies serve as an essential source of early evidence for evaluating compound safety prior to human use.

Objective

This review aims to examine the role of preclinical studies using the zebrafish (Danio rerio) model in supporting clinical decision-making in clinical pharmacy practice.

Methods

This article was conducted using a narrative review approach of national and international scientific literature addressing therapeutic safety, clinical pharmacy, preclinical studies, and the application of the zebrafish model.

Result

The literature indicates that zebrafish offer significant advantages as an efficient, sensitive, and translationally relevant preclinical model for toxicity testing and drug safety assessment, including natural product–based compounds. Integration of preclinical data with clinical considerations contributes to improved accuracy of therapeutic decisions and strengthens the role of clinical pharmacists in ensuring patient safety.

Conclusions

Zebrafish-based preclinical studies represent a significant supportive component in evidence-based clinical pharmacy practice.

Zitieren

APA

Hasdin, F., & Agus, W. (2026). THERAPEUTIC SAFETY AND RATIONALITY IN CLINICAL PHARMACY: THE ROLE OF PRECLINICAL STUDIES AND THE ZEBRAFISH MODEL IN SUPPORTING CLINICAL DECISION-MAKING. JURNAL PHARMA BHAKTA, 6(1), 47-57. https://doi.org/10.56710/jpb.v6i1.169

Vancouver

Hasdin F, Agus W. THERAPEUTIC SAFETY AND RATIONALITY IN CLINICAL PHARMACY: THE ROLE OF PRECLINICAL STUDIES AND THE ZEBRAFISH MODEL IN SUPPORTING CLINICAL DECISION-MAKING. JURNAL PHARMA BHAKTA. 2026;6(1):47-57. doi:10.56710/jpb.v6i1.169

BibTeX
@article{Hasdin2026,
  author = {Hasdin, Fauziah and Agus, Wahyuni},
  title = {THERAPEUTIC SAFETY AND RATIONALITY IN CLINICAL PHARMACY: THE ROLE OF PRECLINICAL STUDIES AND THE ZEBRAFISH MODEL IN SUPPORTING CLINICAL DECISION-MAKING},
  journal = {JURNAL PHARMA BHAKTA},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {47--57},
  doi = {10.56710/jpb.v6i1.169}
}
Kostenlos starten →